Proof and records

What counts as proof in peptide care?

A company logo, a listing in a government drug database and an FDA approval are three different things. Sellers sometimes show the first two as if they meant the third. Start with the claim, then open the public record that can actually answer it.

A reading list with notes, not a list of clinics.

Layered public records, blank index tabs and a magnifying glass on a bright desk
Match each question to the record built to answer it.

Put claims beside records

Use the record that fits the claim

Each question has its own office. FDA’s drug records show whether a medicine is approved. A state board shows whether a doctor or pharmacy is licensed. FDA’s compounding pages explain the rules for medicines a pharmacy mixes itself.

As of September 2026, FDA approval covers a particular drug product for a particular use; it does not attach to the broad word “peptide.”

As of September 2026, even a compounded medicine made by a licensed pharmacy lacks FDA approval.

An NDC number is a National Drug Code: a product code that can appear on a box or a seller’s page.

As of September 2026, an NDC number or an entry in a government drug directory does not mean FDA approved the product.

As of September 2026, a business being “FDA registered,” or a drug being listed with FDA, does not mean FDA approved it.

Which records to trust most

Read from the top down

If the strongest record answers the question, stop there. More marketing does not make the answer stronger.

Drug record or label
Use it for approval, approved uses, warnings and the exact product form.
Law or regulator page
Use it for compounding rules, shortages, registration and enforcement notices.
State board record
Use it to verify a clinician or pharmacy licence and any public discipline.
Doctors’ professional groups
Use them to learn what good practice looks like. For anything that matters, confirm it with your own state board.
Business website
Use it only for what that business says it offers, not as proof that the claim is true.

Annotated reading list

Start with these public sources

These links go to the government sites and professional groups this guide relied on.

Federal regulator

Compounding and the FDA: questions and answers

Best for: the plain distinction between an approved finished drug and a medicine made by a compounder.

Read beside any claim that a compounded product has FDA approval.

Federal regulator

Understanding the risks of compounded drugs

Best for: the quality and review limits that apply before a compounded medicine reaches a patient.

Read before treating “made by a pharmacy” as the same as “approved.”

Federal regulator

FDA concerns about weight-loss products

Best for: current regulator concerns about compounded, fraudulent and research-labelled weight medicines.

Read when a claim compares a product without approval with an approved one.

Federal database

FDA drug shortages

Best for: checking whether a medicine is really on FDA’s national shortage list today. During a national shortage, pharmacies are allowed to make their own copies of a brand-name medicine.

As of September 2026, what counts is FDA’s national shortage list, not one pharmacy being out of stock.

One last check

Records are only part of the check

After checking the records, check the package, the contact route and urgent symptoms.

Next: signs to stop

Private question pad

Save names and records to check

The note stays in this browser on this device. Nothing is sent to this guide.